SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-022382
Filing Date
2021-02-16
Accepted
2021-02-16 06:03:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm216528d1_424b5.htm 424B5 476286
2 GRAPHIC tm216528-1_424b5img001.jpg GRAPHIC 13265
3 GRAPHIC tm216528-1_424b5img002.jpg GRAPHIC 17591
4 GRAPHIC tm216528d1_424b5img003.jpg GRAPHIC 8907
  Complete submission text file 0001104659-21-022382.txt   532624
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-229534 | Film No.: 21631731
SIC: 2834 Pharmaceutical Preparations